145 related articles for article (PubMed ID: 35075611)
1. Constructing a Novel Signature Based on Immune-Related lncRNA to Improve Prognosis Prediction of Cervical Squamous Cell Carcinoma Patients.
Lv X; Liu L; Li P; Yuan Y; Peng M; Jin H; Qin D
Reprod Sci; 2022 Mar; 29(3):800-815. PubMed ID: 35075611
[TBL] [Abstract][Full Text] [Related]
2. Identification of an immune-based mRNA-lncRNA signature for overall survival in cervical squamous cell carcinoma.
Mao Y; Chen R; Xia M; Guo P; Zeng F; Huang J; He M
Future Oncol; 2021 Jun; 17(18):2365-2380. PubMed ID: 33724869
[TBL] [Abstract][Full Text] [Related]
3. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
4. Identification of a 26-lncRNAs Risk Model for Predicting Overall Survival of Cervical Squamous Cell Carcinoma Based on Integrated Bioinformatics Analysis.
Mao Y; Fu Z; Dong L; Zheng Y; Dong J; Li X
DNA Cell Biol; 2019 Apr; 38(4):322-332. PubMed ID: 30698466
[TBL] [Abstract][Full Text] [Related]
5. Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas.
Lin Z; Zou J; Sui X; Yao S; Lin L; Wang J; Zhao J
Sci Rep; 2022 Sep; 12(1):16285. PubMed ID: 36175606
[TBL] [Abstract][Full Text] [Related]
6. A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma.
Mao X; Qin X; Li L; Zhou J; Zhou M; Li X; Xu Y; Yuan L; Liu QN; Xing H
Gynecol Oncol; 2018 Apr; 149(1):181-187. PubMed ID: 29525275
[TBL] [Abstract][Full Text] [Related]
7. A four immune-related long noncoding RNAs signature as predictors for cervical cancer.
Xu M; Zhang R; Qiu J
Hum Cell; 2022 Jan; 35(1):348-359. PubMed ID: 34846702
[TBL] [Abstract][Full Text] [Related]
8. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
9. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.
Qiu Y; Wang X; Fan Z; Zhan S; Jiang X; Huang J
Immun Inflamm Dis; 2021 Dec; 9(4):1596-1612. PubMed ID: 34432955
[TBL] [Abstract][Full Text] [Related]
11. Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma.
Xu Q; Wang Y; Huang W
Int Immunopharmacol; 2021 Mar; 92():107333. PubMed ID: 33486322
[TBL] [Abstract][Full Text] [Related]
12. Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma.
Wang J; Bian Q; Liu J; Moming A
Bioengineered; 2021 Dec; 12(2):10049-10062. PubMed ID: 34872450
[TBL] [Abstract][Full Text] [Related]
13. [Correlation analysis of Poor Prognosis and Immunotherapy of lncRNAs Related with m
Gu R; Liu M; Lin P; Feng TY; Yuan H; Ou DQ; Li SQ; Li Q; Zhao G; Zhang J; Li K
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):626-636. PubMed ID: 35871733
[TBL] [Abstract][Full Text] [Related]
14. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
15. Signature involved in immune-related lncRNA pairs for predicting the immune landscape of cervical cancer.
Liu X; Wang Z; Wang L; Wang Y; Wang Y; Yang S; Zhang Y
Int J Biol Markers; 2022 Jun; 37(2):191-199. PubMed ID: 35435763
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
17. Identification and Experimental Validation of Immune-Associate lncRNAs for Predicting Prognosis in Cervical Cancer.
Ye J; Chen X; Lu W
Onco Targets Ther; 2021; 14():4721-4734. PubMed ID: 34526775
[TBL] [Abstract][Full Text] [Related]
18. A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma.
Qin R; Cao L; Ye C; Wang J; Sun Z
BMC Med Genomics; 2021 Feb; 14(1):49. PubMed ID: 33588862
[TBL] [Abstract][Full Text] [Related]
19. Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.
Wang R; Li Y; Du P; Zhang X; Li X; Cheng G
Life Sci; 2019 Sep; 233():116708. PubMed ID: 31369759
[TBL] [Abstract][Full Text] [Related]
20. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
